CRISPR Breakthrough Blocks SARS-CoV-2 Virus Replication in E

CRISPR Breakthrough Blocks SARS-CoV-2 Virus Replication in Early Lab Tests


AFP
14 JULY 2021
Scientists have used CRISPR gene-editing technology to successfully block the transmission of the SARS-CoV-2 virus in infected human cells, according to research released Tuesday that could pave the way for COVID-19 treatments.
 
Writing in the journal
Nature Communications, researchers in Australia said the tool was effective against viral transmissions in lab tests, adding that they hoped to begin animal trials soon.
CRISPR, which allows scientists to alter DNA sequences and modify gene function, has already shown promise in eliminating the genetic coding that drives the development of children's cancer.
The team in Tuesday's study used an enzyme, CRISPR-Cas13b, that binds to relevant RNA sequences on the novel coronavirus and degrades the genome it needs to replicate inside human cells.

Related Keywords

Australia , Mohamed Fareh , Sharon Lewin , Nature Communications , Peter Maccallum Cancer Centre , Australia Peter Doherty Institute For Infection , Peter Doherty Institute , ஆஸ்திரேலியா , ஷரோன் லெவின் , இயற்கை தகவல்தொடர்புகள் , பீட்டர் மக்காலம் புற்றுநோய் மையம் , ஆஸ்திரேலியா பீட்டர் டோவர்டீ நிறுவனம் க்கு தொற்று , பீட்டர் டோவர்டீ நிறுவனம் ,

© 2025 Vimarsana